Nitric Oxide and Hemodialysis-Induced Hypotension

  1. Koji Yokokawa, MD, PhD;
  2. K. Anil Mandal, MD; and
  3. Mohammad G. Saklayen, MD
  1. Osaka City University Medical School; Osaka 545, Japan Wright State University; Dayton, OH 45428

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    IN RESPONSE:

    Dr. Perazella has raised an important question about a possible relation between hematocrit and plasma nitric oxide levels that may affect the lowering of blood pressure by heparin.

    We compared hematocrit values and plasma ferritin levels in patients who had a hypotensive episode during hemodialysis with those of patients who did not have a hypotensive episode. No significant difference was seen in hematocrit values or plasma ferritin levels (P > 0.2 for both comparisons) between the two groups, as shown by an unpaired t-test. Simple regression analysis showed no significant correlation between plasma nitric oxide levels after hemodialysis and hematocrit values (P > 0.2). Furthermore, no significant correlation was seen between hematocrit values and mean blood pressure after hemodialysis (P > 0.2), suggesting that changes in hematocrit do not contribute to the release or production of nitric oxide between the two groups.

    Koji Yokokawa, MD, PhD

    Osaka City University Medical School

    Osaka 545, Japan

    Anil K. Mandal, MD

    Mohammad G. Saklayen, MD

    Wright State University

    Dayton, OH 45428

    « Previous | Next Article »Table of Contents

    Navigate This Article

    1. Top